Total Funding
91
71
Total FundingFunding Round raised
Growth Score
1 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
65814
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.
- Shou-Ching Jaminet: Chief ScientistPast Role: Beth Israel Deaconess Medical Center, Director, Laboratory of Multi-Gene Transcriptional Profiling
- Harold Dvorak: CMOPast Role: Beth Israel Deaconess Medical Center, Chief of the Department of Pathology
About the Company
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis. Angiex’s lead product is an antibody-drug conjugate therapy for cancer. Angiex was launched with IP from Beth Israel Deaconess Medical Center, is resident at LabCentral in
Cambridge.
Women Founded
